Detalles de la búsqueda
1.
Assessment of the Safety and Immunogenicity of 2 Novel Vaccine Platforms for HIV-1 Prevention: A Randomized Trial.
Ann Intern Med
; 164(5): 313-22, 2016 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26833336
2.
Vector choice determines immunogenicity and potency of genetic vaccines against Angola Marburg virus in nonhuman primates.
J Virol
; 84(19): 10386-94, 2010 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-20660192
3.
Adenoviral Type 35 and 26 Vectors with a Bidirectional Expression Cassette in the E1 Region Show an Improved Genetic Stability Profile and Potent Transgene-Specific Immune Response.
Hum Gene Ther
; 29(3): 337-351, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-28816084
4.
A prophylactic multivalent vaccine against different filovirus species is immunogenic and provides protection from lethal infections with Ebolavirus and Marburgvirus species in non-human primates.
PLoS One
; 13(2): e0192312, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29462200
5.
Correction: A prophylactic multivalent vaccine against different filovirus species is immunogenic and provides protection from lethal infections with Ebolavirus and Marburgvirus species in non-human primates.
PLoS One
; 13(4): e0196546, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29689118
6.
Randomized, placebo-controlled trial to assess the safety and immunogenicity of an adenovirus type 35-based circumsporozoite malaria vaccine in healthy adults.
Hum Vaccin Immunother
; 9(12): 2548-57, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-23955431
7.
Ad35 and ad26 vaccine vectors induce potent and cross-reactive antibody and T-cell responses to multiple filovirus species.
PLoS One
; 7(12): e44115, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-23236343
Resultados
1 -
7
de 7
1
Próxima >
>>